Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.

Bound Wisconsin manager Travis Wilson said in a statement the showcase is "shaping up to be one of the top in-season events in Wisconsin once again," while Bucks executive Michael Belot called Fiserv ...

Taking control of Ocular would also give Sanofi access to its drug delivery platform Elutyx, which could have applications ...

Pfizer is preparing for a market for obesity drugs on par with the booming business created by erectile dysfunction drug ...

Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to appease jittery investors.

Pfizer heads into 2026 with a share price still shaped by the boom and bust of COVID products and a shareholder base that increasingly cares more about income than growth. The company's dividend has ...

Pfizer Inc. enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution, despite an aggressive strategic repositioning. The $10 billion Metsera acquisition ...

A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several hemophilia advocacy groups confirmed this week. Pfizer is now working with its ...

Warner Bros. Discovery plans to recommend existing Netflix deal as soon as Wednesday. Pepsi Worked to Keep Prices Higher at Retailers to Protect Walmart, FTC Found The allegations were made in an FTC ...

Pfizer Inc. forecast little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions. Revenue in 2026 will be $59.5 ...